Valiant Laboratories Ltd: Certificate under SEBI Reg. 74(5) for Q3 FY26
Valiant Laboratories Limited received a certificate under SEBI Regulation 74(5) for the quarter ended December 31, 2025. The company's RTA confirmed the regulation's non-applicability as all securities are in dematerialized form, with no requests for dematerialization or cancellation received.
This is a standard regulatory filing confirming the dematerialized status of shares. It does not introduce new material information that would significantly affect the company's operations or market valuation.
The announcement is a routine compliance filing and does not contain any new financial information or significant corporate actions that would impact the company's stock positively or negatively.
Valiant Laboratories Limited has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate was received from MUFG Intime India Private Limited, the company's Registrar and Share Transfer Agent.
The certificate confirms that the said regulation is not applicable to Valiant Laboratories Limited for the quarter ended December 31, 2025. This is because all of the company's securities are held in dematerialized form. Consequently, no requests for dematerialization, mutilation, or cancellation of securities were received by the company, its RTA, or by the Depository Participants during the specified quarter.
The company has also uploaded this intimation on its official website, www.valiantlabs.in, for public access.
What to do with a filing like this
Valiant Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Valiant Laboratories Limited. Read the original for the full detail.